SLS SELLAS Life Sciences Group Inc

$SLS Fox News has hosted Angelos three times, including around the interim analysis, when hopes were high for an early efficacy halt. The final readout is coming. For #AML patients, including my mother, the stakes are deeply personal. One AML doctor told me the survival seen so far was unlike anything they had heard of before. Having Thomas Fleming involved as a biostatistician in IDMC feels like both a blessing and a curse: the wait is frustrating, but I value rigorous trial design and analysis.

$SLS laugh all you want , No company has ever announced a 600 sq ft booth at ASH show then 2 months later announced a failed drug 🤔 just a little common sense tells you that .

$SLS This daily action is all expected imo. In Biotech Ph3 readouts, large numbers of retail investors do not manage to hang on to reap the rewards, they get shaken out by MMs who cause price shocks in order to accumulate shares from retail. 2 examples: Sarepta Therapeutics ($SRPT) — SRP-9001 (Duchenne Muscular Dystrophy): Ahead of key trial readouts, heavy retail profit-taking and media noise created sharp 15%–20% drawdowns. Institutional filings later revealed major funds (e.g., Baker Bros., BlackRock) used these artificial sell-offs to quietly expand long positions before the regulatory catalyst. Axsome Therapeutics ($AXSM) — Phase 3 GEMINI (Depression): In the months prior to unblinding, $AXSM experienced prolonged sideways range-bound trading and sudden price drops on zero fundamental news. Institutional ownership steadily climbed from <20% to over 60% as retail investors grew fatigued by timeline delays and surrendered their shares.

$SLS $CAPR From CAPR community to SLS Hold on Bulls don't let "sell the news " trick get you down.....

$SLS $SLS Not entirely true. The data is out there if you actually look. CR2 non-transplant historical numbers sit mostly in a tight range: Burnett 2013, Kurosawa 2010, Ganzel 2018, Forman & Rowe 2013, Breems 2005, Bataller 2024, van der Maas 2025, PETHEMA 2026, Maiti 2020, Samuels 2026. No clean non-transplant CR2 cohort has shown a strong long-term plateau. CR1 looks better (QUAZAR, Kugler, PARADIGM, VIALE-A), but that’s a different population. Today’s Nature paper (VEN-based therapy, 11.4 mo mOS, 5% transplant, de novo patients) only reinforced what was already visible across the set. If you’ve spent months digging through every paper, every forum post, every update day after day, you already know what you’re waiting for. You also know the plateau. You know post-transplant data doesn’t apply here. You know what the design assumed and what the real-world numbers have shown. You did the work

$SLS if someone had told you 23 months ago that it would take 23 months for 80 events to happen then you would have gone all in because that would be unheard of. And here we are.

$SLS I'm definitely not a "professional" investor. Admittedly, it took me far too long, and cost me far too many $$, to learn how the true professionals (and deep-pocketed manipulators) function in the stock market. I still have a ton to learn, and this has been a 40+ year process for me. However, I have learned enough to feel very confident that this pullback in share price since the 80th event announcement is a coordinated effort to "shake the trees, and rake the leaves". I will not be shook out this time.

$SLS The real bitch of this is: 80th happened a few weeks ago and they either submitted to ASH with topline HR or a raw event count that was crazily skewed towards GPS survival. They'll get in late breaking, but at what cost? Retailer's sanity and a lot of their gains will be unrealized when they sell too soon. Let's just hope that ASH gets back to them ASAP. We don't need to know the numbers if we can just know they were accepted late breaking. It will imply success.

$SLS didn’t sell at $15, ain’t selling at this stupid price too. Probably my last biotech investment after this end, this rollercoaster ride is giving me ptsd

$SLS She's oversold. LOL. How many fake shares were used? T-1 halt is coming and those debts will be due. 😎

$SLS did SuperBat ever make headline news? I didn’t think so. Relax. Data is good. GPS is why this trial took so long to come to a close. We all know it. Nothing has changed. #40billy #godzilla

$SLS Although share price is being driven down the option prices are staying high. The MM and shorts love this action because they make up some of their losses with this wide spread between the share price and call option. Totally crooked market but that is the tell. If folks really believed the share price was going to keep dropping then the call price would move down also.

$SLS Personally I have done my dd and the timeline has nothing but supported and strengthend my expectations. Phase 2 was amazing and I expect phase 3 to be even better! 🍀👊

$SLS $SLS $1 million of “outflow”? Are you serious? Please do a little additional research and understand what is truly going on here…look @ pcr, look @ how near term (expiring before May) call option prices (with strike prices all the way up to $30) are being aggressively priced (and purchased)…..what we are witnessing is classic whale accumulation (shares and calls) while they employ their FUD minions to try to shake as many shares loose as possible right before a historic data reveal. Use your brain, do you really believe all of these negative posters out there really care about your financial well-being and are just trying to “help you” save your money? Don’t believe them, don’t believe me, do your own research as everyone has an agenda for THEIR OWN best interest. I will continue to take advantage of this laughable share price suppression and add to my stash of shares and LEAPS as I believe the rewards are coming soon. NFA DYOR FUCK CANCER! #notfuckingselling

$SLS Blackrock just added $8M+ right before the 80th announced. I don't see the tutes panicking...ride out the final bumps.

$SLS for anyone "surprised" by the intraday price plays, check discussions that I had with months ago regarding the drop in the stock price that we expect to take place precisely during this time period (80th announcement to topline to FA) as part of the final act. Do not confuse intraday price movements with the value of the company or the two product that within the next 12 months most likely will be the standard for AML care. Hold what you have or add if you can, don't waste money trying to trade.

$SLS all of you nice and kind investors tell me to sell to protect me! Thank you sooooo much! :* Can you also tell me what should I do with this new rental property? Should I rent each unit for $1? Will this be okay? Thank you for you advice!

$SLS with regal results coming in few weeks also sls009 in line with q4 selling now is definitely a face palm. Those selling now really dont deserve the money that is to come.

$SLS Going for a walk! Sharing some photos from Cornell Botanic Gardens. 🌿 Patience everyone!!!

$SLS If you’re here to bash a cancer vaccine platform, paid or not, you are simply scum.